Invasive Transitional Cell Carcinoma (TCC) is the most common type of bladder cancer in dogs. This article delves into the specifics of TCC, providing valuable information for pet owners.
Overview of TCC: TCC is a tumor that originates in the cells lining the bladder wall of dogs. It is distinct from other types of bladder cancers, such as Leimyosarcomas and Fibrosarcomas, in both its origin and behavior. TCC tends to be aggressive and can spread to other parts of the body, including lymph nodes.
Symptoms and Diagnosis: The symptoms of TCC are often similar to those of a urinary tract infection (UTI). These include frequent, small urinations, blood in the urine, and incontinence. Unfortunately, these common symptoms can lead to misdiagnosis or delayed diagnosis. When TCC is suspected, veterinarians typically conduct a series of diagnostic tests, including urine analysis, ultrasound, and possibly a biopsy.
Treatment and Management: Treatment options for TCC in dogs vary depending on the stage of the cancer and the overall health of the dog. Options may include surgery, chemotherapy, radiation, or a combination of these. Recently, new medications specifically targeting TCC have been developed, offering additional treatment avenues.
Early detection and treatment are crucial in managing TCC in dogs. Regular veterinary check-ups and paying close attention to changes in your dog’s urinary habits are key. With proper treatment, dogs with TCC can maintain a good quality of life.